In this open-label , randomized controlled trial , @ general medicine and surgery patients with type @ diabetes treated with a basal-bolus regimen were randomized to receive either supplemental insulin ( n = @ ) at bedtime for blood glucose ( BG ) > @ mmol/L or no supplemental insulin ( n = @ ) except for BG > @ mmol/L .